337 related articles for article (PubMed ID: 14974918)
21. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Piperi C; Kalofoutis A; Creatsas G
Clin Endocrinol (Oxf); 2005 Jan; 62(1):37-43. PubMed ID: 15638868
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of glycaemic status in young people with clinical insulin resistance; fasting glucose, fasting insulin or an oral glucose tolerance test?
Garnett SP; Srinivasan S; Birt SG; Ambler GR; Lawrie EA; Cowell CT; Craig ME
Clin Endocrinol (Oxf); 2010 Apr; 72(4):475-80. PubMed ID: 19656159
[TBL] [Abstract][Full Text] [Related]
23. Insulin sensitivity indices of glucose and free fatty acid metabolism in obese children and adolescents in relation to serum lipids.
Reinehr T; Kiess W; Andler W
Metabolism; 2005 Mar; 54(3):397-402. PubMed ID: 15736120
[TBL] [Abstract][Full Text] [Related]
24. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
Crinò A; Di Giorgio G; Manco M; Grugni G; Maggioni A
Horm Res; 2007; 68(2):83-90. PubMed ID: 17337902
[TBL] [Abstract][Full Text] [Related]
25. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
[TBL] [Abstract][Full Text] [Related]
26. Measuring insulin sensitivity in postmenopausal women covering a range of glucose tolerance: comparison of indices derived from the oral glucose tolerance test with the euglycemic-hyperinsulinemic clamp.
Piché ME; Lemieux S; Corneau L; Nadeau A; Bergeron J; Weisnagel SJ
Metabolism; 2007 Sep; 56(9):1159-66. PubMed ID: 17697856
[TBL] [Abstract][Full Text] [Related]
27. Elevated glucose concentrations during an oral glucose tolerance test are associated with the presence of metabolic syndrome in childhood obesity.
Sabin MA; Hunt LP; Ford AL; Werther GA; Crowne EC; Shield JP
Diabet Med; 2008 Mar; 25(3):289-95. PubMed ID: 18307456
[TBL] [Abstract][Full Text] [Related]
28. [Critical evaluation of the oral glucose tolerance test for the diagnosis of insulin resistance in patients with polycystic ovary syndrome].
Calvar CE; Bengolea SV; Hermes R; Loyato M
Medicina (B Aires); 2007; 67(1):1-7. PubMed ID: 17408014
[TBL] [Abstract][Full Text] [Related]
29. Menopause, but not age, is an independent risk factor for fasting plasma glucose levels in nondiabetic women.
Otsuki M; Kasayama S; Morita S; Asanuma N; Saito H; Mukai M; Koga M
Menopause; 2007; 14(3 Pt 1):404-7. PubMed ID: 17213751
[TBL] [Abstract][Full Text] [Related]
30. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?
Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S
Diabet Med; 2004 Jul; 21(7):730-7. PubMed ID: 15209766
[TBL] [Abstract][Full Text] [Related]
31. [Insulin release and daily glucose change in polycystic ovary syndrome women with normal glucose tolerance].
Tao MF; Zhu JP; Zhou J; Lu W; Qin W; Teng YC; Jia WP
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):659-63. PubMed ID: 19595057
[TBL] [Abstract][Full Text] [Related]
32. Effect of body composition on indices of insulin sensitivity and beta-cell function in healthy men.
Cervenakova Z; Ksinantova L; Koska J
Endocr Regul; 2002 Jun; 36(2):73-7. PubMed ID: 12207556
[TBL] [Abstract][Full Text] [Related]
33. Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess.
Lázaro I; Díaz M; Cabré A; Masana L; Ibáñez L
Gynecol Endocrinol; 2011 Nov; 27(11):935-9. PubMed ID: 21605000
[TBL] [Abstract][Full Text] [Related]
34. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
[TBL] [Abstract][Full Text] [Related]
35. Insulin resistance and hypertension in postmenopausal women.
Feldstein CA; Akopian M; Renauld A; Olivieri AO; Cauterucci S; Garrido D
J Hum Hypertens; 2002 Mar; 16 Suppl 1():S145-50. PubMed ID: 11986914
[TBL] [Abstract][Full Text] [Related]
36. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome].
Wang Y; Mao WW; Chen YJ; Li MZ; Qiao J; Wang LN
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):756-60. PubMed ID: 18307903
[TBL] [Abstract][Full Text] [Related]
37. Lewis phenotypes and the insulin resistance syndrome in young healthy white men and women.
Clausen JO; Hein HO; Suadicani P; Winther K; Gyntelberg F; Pedersen O
Am J Hypertens; 1995 Nov; 8(11):1060-6. PubMed ID: 8554728
[TBL] [Abstract][Full Text] [Related]
38. Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons.
Vogeser M; König D; Frey I; Predel HG; Parhofer KG; Berg A
Clin Biochem; 2007 Sep; 40(13-14):964-8. PubMed ID: 17583689
[TBL] [Abstract][Full Text] [Related]
39. Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents?
Bacha F; Saad R; Gungor N; Arslanian SA
Diabetes Care; 2006 Jul; 29(7):1599-604. PubMed ID: 16801585
[TBL] [Abstract][Full Text] [Related]
40. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
